Amy N. Courtney

发表

CHARACTERIZATION OF ALPHA-GALACTOSYLCERAMIDE AS A MUCOSAL ADJUVANT

Amy N. Courtney, 2010 .

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system.

Daofeng Liu, M. Hensel, Amy N. Courtney, 2014, Cancer research.

NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma

Daofeng Liu, B. Liu, Amy N. Courtney, 2019, Clinical Cancer Research.

IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy

B. Liu, Amy N. Courtney, L. Metelitsa, 2018, The Journal of Immunology.

Title: Glypican-3-specific CAR T cells co-expressing IL15 and IL21 have superior expansion and antitumor activity against hepatocellular carcinoma Authors:

Julien Balzeau, Amy N. Courtney, Meng-fen Wu, 2020 .

Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma

R. Shaik, Julien Balzeau, Amy N. Courtney, 2020, Cancer Immunology Research.

Development of an Effective Cancer Vaccine Using Attenuated Salmonella and Type III Secretion System to Deliver Recombinant Tumor-Associated Antigens Running title : Bacterial genes enable design of effective cancer vaccine

Daofeng Liu, M. Hensel, Amy N. Courtney, 2014 .

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.

C. Liu, Chun Xing Li, P. Hwu, 2009, Vaccine.

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

Eugene S. Kim, Daofeng Liu, S. Asgharzadeh, 2012, The Journal of clinical investigation.

C‐Glycosphingolipids with an exo‐Methylene Substituent: Stereocontrolled Synthesis and Immunostimulation of Mouse and Human Natural Killer T Lymphocytes

R. Bittman, Amy N. Courtney, L. Metelitsa, 2012, Chembiochem : a European journal of chemical biology.

TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells

Christopher J. Miller, S. Ziegler, Shao-Cong Sun, 2009, Proceedings of the National Academy of Sciences.

Intranasal but not intravenous delivery of the adjuvant α‐galactosylceramide permits repeated stimulation of natural killer T cells in the lung

Dapeng Zhou, Amy N. Courtney, P. Thapa, 2011, European journal of immunology.

1 Expression of the G-CSF receptor, CD114, marks a novel, highly tumorigenic cell population in a neuroblastoma cell line

P. Gunaratne, C. Coarfa, Ashley L. Benham, 2013 .

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Tali Raveh-Sadka, Xin Xu, Nisha Ghatwai, 2020, Nature Medicine.

Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.

Daofeng Liu, Hao Liu, E. Yvon, 2014, Blood.

Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens.

Dapeng Zhou, Amy N. Courtney, P. Thapa, 2009, Vaccine.

Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Tali Raveh-Sadka, Bin Liu, Nisha Ghatwai, 2020, Nature Medicine.

G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic.

Eugene S. Kim, P. Gunaratne, S. Agarwal, 2013, Cancer research.

Expression of the G-CSF receptor , CD 114 , marks a novel , highly tumorigenic cell population in a neuroblastoma cell line

Eugene S. Kim, P. Gunaratne, S. Agarwal, 2013 .

A Nanoradiomics Approach for Differentiation of Tumors Based on Tumor-Associated Macrophage Burden

K. Ghaghada, A. Annapragada, Amy N. Courtney, 2021, Contrast media & molecular imaging.

Animal Models in AIDS Research

Amy N. Courtney, P. Nehete, K. Sastry, 2011, Handbook of Laboratory Animal Science.

Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma

Julien Balzeau, Amy N. Courtney, L. Metelitsa, 2023, Journal for ImmunoTherapy of Cancer.

CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo.

Daofeng Liu, Q. Mo, Amy N. Courtney, 2016, The Journal of clinical investigation.

Title: Invariant NKT Cells with Chimeric Antigen Receptor Provide a Novel Platform for Safe and Effective Cancer Immunotherapy Short title: NKT-cell platform for cancer immunotherapy

Daofeng Liu, Hao Liu, E. Yvon, 2017 .

Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection.

A. Chopra, Amy N. Courtney, P. Nehete, 2007, Vaccine.

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Daniel K. Wells, Chenling A. Xu, Meena Subramaniam, 2023, Nature Medicine.

LEF1 drives a central memory program and supports antitumor activity of natural killer T cells.

J. Rosen, Julien Balzeau, Amy N. Courtney, 2022, Cancer immunology research.

Natural killer T cells and other innate-like T lymphocytes as emerging platforms for allogeneic cancer cell therapy.

Amy N. Courtney, L. Metelitsa, Gengwen Tian, 2022, Blood.

Multicolor flow cytometry analyses of cellular immune response in rhesus macaques.

Amy N. Courtney, K. Sastry, E. Wieder, 2010, Journal of visualized experiments : JoVE.

Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis

C. Ramos, Amy N. Courtney, R. Kamble, 2021, Blood.

IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.

Eugene S. Kim, Daofeng Liu, S. Asgharzadeh, 2012, The Journal of clinical investigation.

Abstract IA09: Harnessing natural and engineered properties of NKT cells for cancer immunotherapy

Amy N. Courtney, G. Dotti, A. Heczey, 2019, Tackling the Tumor Microenvironment: Beyond T-cells.

Off-the-Shelf CD19-Specific CAR-NKT Cells in Patients with Relapsed or Refractory B-Cell Malignancies

C. Ramos, Amy N. Courtney, R. Kamble, 2024, Transplantation and Cellular Therapy.

Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.

Nisha Ghatwai, A. Montalbano, Amy N. Courtney, 2024, Nature medicine.